Combined therapy in metabolic syndrome treatment
According to the latest recommendations by the European Society of Hypertension and the European Society of Cardiology, in patients with high cardiovascular risk (including individuals with diabetes mellitus and metabolic syndrome), the first-choice agents for arterial hypertension (AH) treatment ar...
Saved in:
| Main Authors: | Yu. V. Zhernakova, V. B. Mychka, I. E. Chazova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2010-08-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2111 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combined antihypertensive therapy in treating patients with metabolic syndrome
by: V. B. Mychka, et al.
Published: (2008-06-01) -
Metabolic syndrome treatment: focusing on acarbose
by: I. E. Chazova, et al.
Published: (2008-04-01) -
Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01) -
Moxonidine-based combination antihypertensive therapy in patients with metabolic syndrome
by: E. V. Tishina, et al.
Published: (2012-06-01) -
Cerebrovascular events primary prevention in metabolic syndrome patients
by: V. B. Mychka, et al.
Published: (2006-04-01)